19 /100
LOW RISK
Score updated May 29, 2026

GYRE — Gyre Therapeutics, Inc. Dilution Risk Tracker

Track GYRE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GYRE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
65
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GYRE.
🔔 Track GYRE — Get forecast alerts →

💹 Market Data

Market Cap$556.94M
Shares Outstanding97.03M
Float21.28M
Cash$49.81M
Debt$823.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.5% shares (2025Q4 vs prior)
45 institutional holders · 3.39M shares
#1 VANGUARD GROUP INC 1.20M shares
#2 BlackRock, Inc. 720.3K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 423.2K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.58M
Days to Cover32.6
% of Float7.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2018
8-K 8K EVENT May 04, 2026
8-K 8K EVENT Mar 02, 2026
4 INSIDER TRANSACTION Jan 09, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track GYRE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GYRE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for GYRE
📊 GYRE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GYRE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.